Mattner F, Bitz F, Goedecke M, Viertel A, Kuhn S, Gastmeier P, Mattner L, Biertz F, Heim A, Henke-Gendo C, Engelmann I, Martens A, Strüber M, Schulz T F
Institute of Medical Microbiology and Hygiene, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.
Infection. 2007 Jun;35(4):219-24. doi: 10.1007/s15010-007-6277-7. Epub 2007 Jul 23.
The recent unfortunate rabies transmissions through solid organ transplants of an infected donor in Germany required the initiation of a vaccination program to protect health care workers (HCWs) with close contact to rabies-infected patients. A systematic follow-up of adverse effects was initiated. Rabies postexposure prophylaxis (PEP) was started in 269 HCWs at four German hospitals. Pre-exposure prophylaxis (PreEP) was administered to 74 HCWs caring for an already diagnosed rabies patient. At each vaccination date, HCWs were interviewed for symptoms possibly representing adverse effects. Adverse effects of PEP and PrePEP were compared. Out of 269 HCWs, 216 were included for the investigation of adverse effects. Of these 216 HCWs, 114 (53%) individuals developed at least one systemic adverse effect. Incidences of tiredness (30.6%), malaise (26.4%), headache (26.9%), dizziness (14.8%), and chills (13.0%) declined in the course of PEP (p < 0.05), whereas incidences of fever (7.4%), paraesthesias (7.9%), arthralgias (1.9%), myalgias (4.2%), nausea (9.3%), diarrheas (2.8%) and vomiting (1.4%) did not. In 11 (5.1%) HCWs PEP was discontinued mostly due to adverse reactions (four suffered strong headaches, two HCWs meningeal irritations, two chills, one paraesthesia, one malaise, and one a rush). Systemic effects of PEP or PreEP did not differ significantly. Despite relatively high incidences of moderate severe adverse reactions rabies PEP is safe. Strong headache, tiredness, dizziness, and paraesthesias are the most important postvaccinal symptoms. Vaccinees suffering from adverse effects of PEP must be strongly encouraged to complete PEP, as it is to date the only protection against fatal rabies.
最近在德国,一名感染狂犬病的捐赠者通过实体器官移植导致了不幸的狂犬病传播事件,这就需要启动一项疫苗接种计划,以保护与狂犬病感染患者有密切接触的医护人员(HCWs)。同时还启动了对不良反应的系统随访。德国四家医院的269名医护人员开始接受狂犬病暴露后预防(PEP)。74名照顾已确诊狂犬病患者的医护人员接受了暴露前预防(PreEP)。在每次接种疫苗时,都会询问医护人员是否有可能代表不良反应的症状。对PEP和PrePEP的不良反应进行了比较。在269名医护人员中,216名被纳入不良反应调查。在这216名医护人员中,114名(53%)至少出现了一种全身性不良反应。在PEP过程中,疲劳(30.6%)、不适(26.4%)、头痛(26.9%)、头晕(14.8%)和寒战(13.0%)的发生率下降(p<0.05),而发热(7.4%)、感觉异常(7.9%)、关节痛(1.9%)、肌肉痛(4.2%)、恶心(9.3%)、腹泻(2.8%)和呕吐(1.4%)的发生率没有下降。11名(5.1%)医护人员因不良反应大多中断了PEP(4人严重头痛,2人有脑膜刺激症状,2人寒战,1人感觉异常,1人不适,1人皮疹)。PEP或PreEP的全身性影响没有显著差异。尽管狂犬病PEP出现中度至重度不良反应的发生率相对较高,但它是安全的。强烈头痛、疲劳、头晕和感觉异常是最重要的接种后症状。必须大力鼓励遭受PEP不良反应的接种者完成PEP,因为这是迄今为止预防致命狂犬病的唯一保护措施。